While TNBC represents a highly diverse group of cancers, it can be characterized by a lack of the estrogen receptor (ER) and progesterone receptor (PR) and by the absence of overexpression of the human epidermal growth factor receptor 2 (HER2) [4]. This evidence concerns the gene ESR1 and cancer.